Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263653
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2005-12-08
Brief Title:
Safety Reactogenicity Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals Hib-MenC Given With Priorix in Toddlers 13-14 m Primed With 3 Doses of Hib and MenC-CRM197
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
103954
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None